|
PROTEOLYTIC ACTIVATION OF PROTHROMBIN The serine
protease α-thrombin is produced by
proteolytic activation of the zymogen, prothrombin. The enzyme complex,
prothrombinase,
catalyzes the proteolysis of two peptide bonds in
prothrombin, which gives rise to an NH2-terminal
derived F1.2 region and the heterodimer, α-thrombin.
Alpha-thrombin is composed of an "A" chain (Mr=6000) which is covalently linked
to a "B" chain (Mr=31,000) through a single disulfide bond.
Alpha-thrombin is a highly specific serine protease generated by proteolytic activation of the zymogen
prothrombin (1). During coagulation, thrombin cleaves
fibrinogen to form fibrin, leading to the ultimate step in coagulation, the formation of a fibrin clot. Thrombin is also responsible for feedback activation of the procofactors
factor V and factor VIII. Thrombin has also been reported to activate
factor XIII and platelets, and also functions as a vasoconstrictor protein. The procoagulant activity of thrombin is arrested in two ways: 1) inhibition by either
heparin cofactor II or the
antithrombin III/heparin complex; or 2) complex formation with
thrombomodulin. Formation of the thrombin/thrombomodulin complex results in the inability of thrombin to cleave fibrinogen and activate factors V and VIII, but increases the efficiency of thrombin for activation of the anticoagulant,
protein C.
Thrombin is a two chain enzyme composed of an NH2-terminal "A" chain (Mr=6,000) and a COOH-terminal "B" chain (Mr=31,000) which remain covalently associated through a single disulfide bond. Human thrombin is 13 amino acids shorter than the bovine thrombin due to a thrombin cleavage site on the human protein that is not present in the bovine protein.
Thrombin is also utilized for site specific cleavage of fusion proteins expressed in bacteria (9-11). A thrombin sensitive site is incorporated between the recombinant protein of interest and peptides or proteins which facilitate purification and/or expression. The target protein is released from the expressed hybrid by cleavage with thrombin. Thrombin can then be easily removed by affinity chromatography.
Human, bovine and mouse thrombin are prepared from purified prothrombin using a modification of the Lundblad procedure (1) as described by Nesheim et al. (2). Thrombin is supplied in 50% (vol/vol)
glycerol/H2O and should be stored at
-20oC. Purity is determined by SDS-PAGE analysis and activity is measured in a thrombin specific clotting assay, and compared to standardized NIH thrombin. Thrombin is also available with the active site blocked with either DFP, FPRck, or biotinlyated FPRck.
Properties of
Thrombin
| Localization: |
Plasma |
| Mode of action: |
Serine protease which cleaves fibrinogen to form fibrin; also responsible for
activation of protein C, platelet activation and feedback activation of the
procofactors,
factor V and factor VIII |
| Molecular weight: |
36,700 (3-6) |
| Extinction coefficient: |
| E |
|
= 18.3 (human) (6) |
|
|
= 19.5 (bovine) (7) |
|
| Specific Activity: |
approximately 3800 NIH units/mg |
| Isoelectric point: |
7.0-7.6 (human) (3) |
| Structure: |
two subunits, approximately
Mr=6,000 and 31,000 |
| Percent carbohydrate: |
approximately 5% |
|
Catalog
Number |
Description |
|
HCT-0020 |
Human α-Thrombin
(Compliment
fluorogenic substrate(s): HTI Catalog # SN-17a,
SN-20, and SN-59) |
|
HCT-DFP |
Human α-Thrombin-DFP |
|
HCT-FPRCK |
Human α-Thrombin-FPRck
(FPR-chloromethylketone) |
|
HCT-BFPRCK |
Human α-Thrombin-BFPRck
(Biotinylated FPR-chloromethylketone) |
|
BCT-1020 |
Bovine α-Thrombin |
|
BCT-DFP |
Bovine α-Thrombin-DFP |
|
BCT-FPRCK |
Bovine α-Thrombin-FPRck
(FPR-chloromethylketone) |
|
BCT-BFPRCK |
Bovine α-Thrombin-BFPRck
(Biotinylated FPR-chloromethylketone) |
|
MCT-5020 |
Mouse Thrombin |
DOWNLOAD
THROMBIN APPLICATION PDF
PRICING
INQUIRE
ABOUT THIS PRODUCT
References
1. Lundblad, R.L., et al., Methods Enzymol., 45, 156 (1976).
2. Nesheim, M.E., et al., J. Biol. Chem., 258, 5386 (1983).
3. Fenton, J.W., et al., in Chemistry and Biology of Thrombin, ed. R.L. Lundblad, J.W. Fenton, K.G. Mann, pp. 43-70. Ann Arbor, MI: Ann Arbor Science Publishers, Inc., 1977.
4. Braughman, D.J., et al., J. Biol. Chem., 242, 5252 (1967).
5. Winzor, D.J., et al., Arch. Biochem. Biophys., 104, 202 (1964).
6. Fenton, J.W., et al., J. Biol. Chem., 252, 3587 (1977).
7. Winzor, D.J., et al., J. Phys. Chem., 68, 338 (1964).
8. Magnusson, S., in The Enzymes, ed. P.D. Boyer, vol. III, pp. 277-321. New York: Academic Press, 1971.
9.Gaun, K.L. and Dixon, J.E., Anal. Biochem., 192, 262 (1991).
10.Germino, J. and Bastia, D., Proc. Natl. Acad. Sci. USA, 81, 4692 (1984).
11.Chang, J.-Y., Eur. J. Biochem., 151, 217 (1985).
|